series-c-plus
Stage
1
Investors
About
Primrose Bio develops and manufactures optimized enzymes, engineered strains, and protein expression systems to enable scalable and consistent production of biotherapeutics and vaccines, including RNA polymerases and carrier proteins for vaccine conjugation.
Explore Primrose Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.